Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.24 USD | -4.74% | -13.40% | +124.15% |
May. 28 | Johnson & Johnson Acquires Experimental Eczema Drug for $1.25 Billion | MT |
May. 15 | Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bullish | Bullish |
Resistance | 8.660 | 12.53 | 11.77 |
Spread/Res. | -16.40% | -42.22% | -38.49% |
Spread/Supp. | +9.04% | +50.21% | +52.90% |
Support | 6.640 | 4.820 | 4.735 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ARQT Stock
- Charts Arcutis Biotherapeutics, Inc.